NDC 51662-1632 – Adenosine

Adenosine 3 mg/mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC51662-1632

Product details

Brand name
Adenosine
Generic name
Adenosine
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
ANDA · ANDA077133
Marketed since
June 23, 2023
Listing expires
December 31, 2026
Pharmacologic class
Adenosine Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Adenosine →

Package NDC codes (1)

Package NDCDescriptionSince
51662-1632-12 mL in 1 VIAL, SINGLE-USE (51662-1632-1)Jun 23, 2023

Other Adenosine products